Medical Device CROs

Chapter Outlines

Chapter 2 is an executive summary of key insights captured during our research. It offers a high-level view on the current state of the medical devices contract research market and its likely evolution in the short to mid-term and long term.

Chapter 3 provides a brief introduction to medical devices, highlighting the key historical and development milestones, and classification of such devices. It also provides a general overview of the concept of CROs, featuring a discussion on the historical evolution of contract research services market in the medical device domain. Further, it presents details related to the various types of CROs that operate within the medical device market and the different types of services offered. It further lists the advantages as well as challenges associated with outsourcing medical device research and clinical operations to contract service providers, along with the key parameters that need to be considered while selecting a CRO partner.

Chapter 4 features a detailed overview of the current market landscape of medical devices CROs, along with information on several relevant parameters, such as their year of establishment, company size (in terms of company size), location of headquarters (North America, Europe, Asia-Pacific, Middle East and North Africa, and Rest of the World), area of specialization (medical device and in vitro diagnostics), device class (class I, class II, and class III), types of services offered by [A] clinical service providers  (biostatistics, consulting, clinical operations, post marketing surveillance / studies, quality assurance, regulatory affairs management, reimbursement and training), [B] preclinical service providers (consulting, biocompatibility testing, materials characterization and analytical testing, preclinical trials support, sterility testing and microbiology testing, and training) and [C] stand-alone service providers.

Chapter 5 features a discussion on the various guidelines established by major regulatory bodies for medical device approvals across North America (the US, Canada and Mexico), Europe (France, Germany, Italy, Spain, the UK and rest of Europe), and  Asia-Pacific and Rest of the World (Australia, Brazil, China, India, Israel, Japan, New Zealand, Singapore, South Africa, South Korea, Taiwan, and Thailand). The report also features an insightful multi-dimensional heat map analysis, featuring a comparison of the contemporary regulatory and reimbursement scenarios in key geographies across the globe.  

Chapter 6 features detailed profiles of key players (shortlisted on the basis of the company competitiveness analysis) engaged in this domain. Each profile features a brief overview of the company, along with information on year of establishment, number of employees, location of headquarters, key executives, details related to contract research services offered, recent developments, and an informed future outlook.

Chapter 7 features an analysis on the key value drivers and performance indicators used by sponsor companies to evaluate service providers engaged in this domain, based on information gathered via secondary research (for top-ten medical device players), as well as credible inputs from primary research.

Chapter 8 presents a competitive benchmarking of the various players engaged in this domain. It highlights the capabilities of small-sized, mid-sized and large companies in terms of their expertise in medical device services. The analysis allows companies to compare their existing capabilities within and beyond their respective peer groups (small, mid-sized and large players based in North America, Europe, Asia-Pacific, and Rest of the World) and providing a means for stakeholders to identify ways to gain a competitive advantage in the industry.

Chapter 9 provides an elaborative brand positioning analysis of leading industry players (shortlisted on the basis of revenues generated in 2021), highlighting the current perceptions regarding their proprietary brands by taking into consideration several relevant aspects, such as number of services offered and device class.

Chapter 10 presents a detailed analysis of completed, ongoing, and planned clinical studies focused on medical devices, based on several relevant parameters, such as trial registration year, trial phase, current trial status, enrolled patient population, study design, leading industry players (in terms of number of trials conducted), target therapeutic area(s) and key geographical regions.

Chapter 11 features a detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022 (till March). It is worth mentioning that the data captured during our research was analysed based on multiple parameters, such as year, type of agreements and geographical location of the companies.

Chapter 12 detailed analysis of the total cost of ownership for a medical device contract research service provider. It features an informed estimate of direct and indirect expenses taking into consideration 19 relevant parameters, over a span of 20 years.

Chapter 13 presents insights from the survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing contract research services to medical device developers.

Chapter 14 presents an insightful market forecast analysis, highlighting the likely growth of the medical devices contract research market till the year 2035. In order to provide details on the future opportunity, our projections have been segmented on the basis of [A] target therapeutic area (Cardiovascular disorders, CNS disorders, Metabolic disorders, Oncological disorders, Ophthalmological disorders, Orthopedic disorders, Pain disorders, Psychological disorders, Respiratory disorders, and Others), [B] scale of operation (clinical and preclinical), [C] device class (class I, class II and class III), [D] types of clinical services offered (clinical trial management, consulting, data management, regulatory affairs management and others) [E] types of preclinical services offered (material characterization and analytical services, biocompatibility testing, sterility and microbiology testing and others), and [F] key geographical regions (North America, Europe, Asia-Pacific and Rest of the World). 

Chapter 15 provides a discussion on industry affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the evolution of this field; it includes a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on industry dynamics.

Chapter 16 presents a discussion on the upcoming opportunities / trends of medical device contract services market that are likely to impact the future evolution of this domain over the coming years. These include (but not limited to) growth in number of connected devices, adoption of data analytics and real-time monitoring solutions, growing need for cloud-based computing and storage solutions and growing demands for real-world evidence to obtain regulatory approval. 

Chapter 17 is a collection of interview transcripts of the discussions held with key stakeholders in this market. In this chapter, we have presented the details of interview held with Lajos Sarosi (Chief Executive Officer and Co-founder, HungaroTrial), Lee King (Senior Vice President, Business Development and Marketing), Christopher Rupp (Vice President of Global Marketing and Commercial Operations, NAMSA), Claus Hemiker (Head, Business Development), Christian Wolflehner (General Manager, CW Research & Management), Troy Mccall (Chief Operating Officer, CROMSOURCE), Nazish Urooj (Senior Manager, Medical & Clinical Operations, Metrics Research), C. Omprakash (Technical Director and Partner, Vyomus Consulting), Tania Persson (Director of Business Development, A+ Science) and Alexa Foltin-Mertgen (Business Development Manager, AtoZ-CRO).

Chapter 18 is an appendix that contains tabulated data and numbers for all the figures provided in the report.

Chapter 19 is an appendix that provides the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY
2.1. Chapter Overview

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Medical Devices
3.2.1. Historical Evolution of Medical Devices
3.2.2. Classification of Medical Devices
3.3. Overview of Contract Research Organizations (CROs)
3.3.1. Evolution of CROs
3.4. Role of CROs in the Medical Device Industry

3.5. Types of Medical Device CROs
3.6. Types of Services Offered by CROs
3.7. Advantages of Outsourcing Operations to CROs
3.8. Risks and Challenges Associated with Outsourcing
3.9. Key Considerations WhileSelecting a Suitable CRO Partner

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Medical Device CROs: Clinical Service Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Area of Specialization
4.2.6. Analysis by Device Class
4.2.7. Analysis by Type of Clinical Operation Service Offered
4.2.8. Analysis by Type of Regulatory Affairs-related Service Offered
4.2.9. Analysis by Type of Additional Service Offered
4.2.10. Analysis by Medical Device Regulatory Compliance Authority

4.3. Medical Device CROs: Preclinical Service Providers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Company Size and Location of Headquarters
4.3.5. Analysis by Type of Preclinical Service Offered

4.4. Medical Device CROs: Standalone Service Providers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters
4.4.4. Analysis by Company Size and Location of Headquarters

5. REGULATORY AND REIMBURSEMENT LANDSCAPE FOR MEDICAL DEVICES
5.1. Chapter Overview
5.2. General Regulatory and Reimbursement Guidelines for Medical Devices

5.3. Regulatory and Reimbursement Landscape in North America
5.3.1. The US Scenario
5.3.1.1. Regulatory Authority
5.3.1.2. Review / Approval Process
5.3.1.3. Reimbursement Landscape
5.3.1.3.1. Payer Mix
5.3.1.3.2. Reimbursement Process

5.3.2. The Canadian Scenario
5.3.2.1. Regulatory Authority
5.3.2.2. Review / Approval Process
5.3.2.3. Reimbursement Landscape
5.3.2.3.1. Payer Mix
5.3.2.3.2. Reimbursement Process

5.3.3. The Mexican Scenario
5.3.3.1. Regulatory Authority
5.3.3.2. Review / Approval Process
5.3.3.3. Reimbursement Landscape
5.3.3.3.1. Payer Mix

5.4. Regulatory and Reimbursement Landscape in Europe
5.4.1. Overall Scenario
5.4.1.1. Overview of Regulatory Authorities
5.4.1.2. Overall Review / Approval Process

5.4.2. The UK Scenario
5.4.2.1. Regulatory Authority
5.4.2.2. Review / Approval Process
5.4.2.3. Reimbursement Landscape
5.4.2.3.1. Payer Mix
5.4.2.3.2. Reimbursement Process

5.4.3. The French Scenario
5.4.3.1. Regulatory Authority
5.4.3.2. Review / Approval Process
5.4.3.3. Reimbursement Landscape
5.4.3.3.1. Payer Mix
5.4.3.3.2. Reimbursement Process

5.4.4. The German Scenario
5.4.4.1. Regulatory Authority
5.4.4.2. Review / Approval Process
5.4.4.3. Reimbursement Landscape
5.4.4.3.1. Payer Mix
5.4.4.3.2. Reimbursement Process

5.4.5. The Italian Scenario
5.4.5.1. Regulatory Authority
5.4.5.2. Review / Approval Process
5.4.5.3. Reimbursement Landscape
5.4.5.3.1. Payer Mix
5.4.5.3.2. Reimbursement Process

5.4.6. The Spanish Scenario
5.4.6.1. Regulatory Authority
5.4.6.2. Review / Approval Process
5.4.6.3. Reimbursement Landscape
5.4.6.3.1. Payer Mix
5.4.6.3.2. Reimbursement Process

5.5. Regulatory and Reimbursement Landscape in Asia-Pacific and Rest of the World
5.5.1. The Australian Scenario
5.5.1.1. Regulatory Authority
5.5.1.2. Review / Approval Process
5.5.1.3. Reimbursement Landscape
5.5.1.3.1. Payer Mix
5.5.1.3.2. Reimbursement Process

5.5.2. The Brazilian Scenario
5.5.2.1. Regulatory Authority
5.5.2.2. Review / Approval Process
5.5.2.3. Reimbursement Landscape
5.5.2.3.1. Payer Mix
5.5.2.3.2. Reimbursement Process

5.5.3. The Chinese Scenario
5.5.3.1. Regulatory Authority
5.5.3.2. Review / Approval Process
5.5.3.3. Reimbursement Landscape
5.5.3.3.1. Payer Mix
5.5.3.3.2. Reimbursement Process

5.5.4. The Indian Scenario
5.5.4.1. Regulatory Authority
5.5.4.2. Review / Approval Process
5.5.4.3. Reimbursement Landscape
5.5.4.3.1. Payer Mix

5.5.5. The Israeli Scenario
5.5.5.1. Regulatory Authority
5.5.5.2. Review / Approval Process
5.5.5.3. Reimbursement Landscape
5.5.5.3.1. Payer Mix

5.5.6. The Japanese Scenario
5.5.6.1. Regulatory Authority
5.5.6.2. Review / Approval Process
5.5.6.3. Reimbursement Landscape
5.5.6.3.1. Payer Mix
5.5.6.3.2. Reimbursement Process

5.5.7. The New Zealand Scenario
5.5.7.1. Regulatory Authority
5.5.7.2. Review / Approval Process
5.5.7.3. Reimbursement Landscape
5.5.7.3.1. Payer Mix
5.5.7.3.2. Reimbursement Process

5.5.8. The Singapore Scenario
5.5.8.1. Regulatory Authority
5.5.8.2. Review / Approval Process
5.5.8.3. Reimbursement Landscape
5.5.8.3.1. Payer Mix
5.5.8.3.2. Reimbursement Process

5.5.9. The South Korean Scenario
5.5.9.1. Regulatory Authority
5.5.9.2. Review / Approval Process
5.5.9.3. Reimbursement Landscape
5.5.9.3.1. Payer Mix
5.5.9.3.2. Reimbursement Process

5.5.10. The South African Scenario
5.5.10.1. Regulatory Authority
5.5.10.2. Review / Approval Process
5.5.10.3. Reimbursement Landscape

5.5.11. The Taiwan Scenario
5.5.11.1. Regulatory Authority
5.5.11.2. Review / Approval Process
5.5.11.3. Reimbursement Landscape
5.5.11.3.1. Payer Mix
5.5.11.3.2. Reimbursement Process

5.5.12. The Thailand Scenario
5.5.12.1. Regulatory Authority
5.5.12.2. Review / Approval Process
5.5.12.3. Reimbursement Landscape

5.6. Comparison of Regional Regulatory Control
5.7. Concluding Remarks

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Avania (Formerly known as Factory CRO)
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Charles River Laboratories
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. CROMSOURCE
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Recent Developments and Future Outlook

6.5. CSSi LifeSciences
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. Eurofins Medical Device Testing
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Recent Developments and Future Outlook

6.7. IQVIA
6.7.1. Company Overview
6.7.2. Service Portfolio
6.7.3. Recent Developments and Future Outlook

6.8. Medpace
6.8.1. Company Overview
6.8.2. Service Portfolio
6.8.3. Recent Developments and Future Outlook

6.9. NAMSA
6.9.1. Company Overview
6.9.2. Service Portfolio
6.9.3. Recent Developments and Future Outlook

6.10. Qserve Group
6.10.1. Company Overview
6.10.2. Service Portfolio
6.10.3. Recent Developments and Future Outlook

6.11. WuXi AppTec
6.11.1. Company Overview
6.11.2. Service Portfolio
6.11.3. Recent Developments and Future Outlook

7. MEDICAL DEVICE DEVELOPER AND CRO RELATIONSHIPS: KEY VALUE DRIVERS AND PERFORMANCE INDICATORS
7.1. Chapter Overview
7.2. Definition and Importance of Key Performance Indicators (KPIs)
7.3. Key Considerations for Selection of KPIs
7.4. Types of KPIs
7.4.1. Financial Indicators
7.4.1.1. Most Important KPIs
7.4.1.1.1. Financial Stability
7.4.1.1.2. Cost of Services Offered
7.4.1.1.3. Comparative Analysis of Financial Indicators

7.4.1.2. Industry Perspective
7.4.1.2.1. Sponsors’ (Big Pharma) Perspective
7.4.1.2.2. Contract Service Providers’ Perspective

7.4.2. Process and Capability Indicators
7.4.2.1. Most Important KPIs
7.4.2.1.1. Proximity to Sponsor
7.4.2.1.2. Capability to Innovate / Mitigate Risk
7.4.2.1.3. Strength of Service Portfolio
7.4.2.1.4. Comparative Analysis of Process / Capability Indicators

7.4.2.2. Industry Perspective
7.4.2.2.1. Sponsors’ (Big Pharma) Perspective
7.4.2.2.2. Contract Service Providers’ Perspective

7.4.3. Market Reputation Indicators
7.4.3.1. Most Important KPIs
7.4.3.1.1. Flexibility / Adaptability
7.4.3.1.2. Time Management
7.4.3.1.3. Quality / Reliability
7.4.3.1.4. Regulatory Compliance / Track Record
7.4.3.1.5. Comparative Analysis of Market Reputation Indicators

7.4.3.2. Industry Perspective
7.4.3.2.1. Sponsors’ (Big Pharma) Perspective
7.4.3.2.2. Contract Service Providers’ Perspective

7.5. Comparison of Key Performance Indicators
7.6. Concluding Remarks

8. COMPETITIVE BENCHMARKING
8.1. Chapter Overview
8.2. Assumptions and Methodology
8.3. Competitive Benchmarking by Region
8.3.1. Competitive Benchmarking: Small Players based in North America (Peer Group I)
8.3.2. Competitive Benchmarking: Mid-sized Players based in North America (Peer Group II)
8.3.3. Competitive Benchmarking: Large Players based in North America (Peer Group III)
8.3.4. Competitive Benchmarking: Small Players based in Europe (Peer Group IV)
8.3.5. Competitive Benchmarking: Mid-sized Players based in Europe (Peer Group V)
8.3.6. Competitive Benchmarking: Large Players based in Europe (Peer Group VI)
8.3.7. Competitive Benchmarking: Small Players based in Asia-Pacific (Peer Group VII)
8.3.8. Competitive Benchmarking: Mid-sized Players based in Asia-Pacific (Peer Group VIII)
8.3.9. Competitive Benchmarking: Large Players based in Asia-Pacific (Peer Group IX)
8.3.10. Competitive Benchmarking: Small Players based in RoW (Peer Group X)
8.3.11. Competitive Benchmarking: Mid-sized Players based in RoW (Peer Group XI)
8.4. Concluding Remarks

9. BRAND POSITIONING OF KEY INDUSTRY PLAYERS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Brand Positioning Matrix: Labcorp
9.4. Brand Positioning Matrix: IQVIA
9.5. Brand Positioning Matrix: Syneos Health
9.6. Brand Positioning Matrix: PPD
9.7. Brand Positioning Matrix: ICON
9.8. Brand Positioning Matrix: Charles River Laboratories
9.9. Brand Positioning Matrix: WuXi AppTec
9.10. Brand Positioning Matrix: Medpace

10. CLINICAL TRIAL ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Medical Devices: Clinical Trial Analysis
10.3.1. Analysis by Trial Registration Year
10.3.2. Analysis by Trial Status
10.3.3. Analysis by Phase of Development
10.3.4. Analysis by Study Design
10.3.5. Analysis by Therapeutic Area
10.3.6. Analysis by Geography
10.3.7. Analysis by Trial Registration Year and Geography
10.3.8. Analysis by Trial Status and Geography
10.3.9. Analysis by Type of Sponsor
10.3.10. Most Active Players: Analysis by Number of Clinical Trials

10.4. Medical Devices: Analysis by Enrolled Patient Population
10.4.1. Analysis by Trial Registration Year
10.4.2. Analysis by Phase of Development
10.4.3. Analysis by Geography
10.4.4. Analysis by Trial Status and Geography

11. MERGERS AND ACQUISITIONS
11.1. Chapter Overview
11.2. Merger and Acquisition Models
11.3. Medical Device CROs: Mergers and Acquisitions
11.3.1. Analysis by Year of Merger / Acquisition
11.3.2. Analysis by Type of Agreement
11.3.3. Regional Analysis
11.3.3.1. Analysis by Continent
11.3.3.2. Intercontinental and Intracontinental Deals
11.3.3.3. Analysis by Country

11.3.4. Ownership Change Matrix
11.3.5. Analysis by Type of Company
11.3.6. Analysis by Key Value Drivers
11.3.6.1. Analysis by Year of Acquisition and Key Value Drivers

12. TOTAL COST OF OWNERSHIP IN MEDICAL DEVICES CONTRACT RESEARCH ORGANIZATION
12.1. Chapter Overview
12.2. Assumptions and Methodology
12.3. Expenditures Incurred by a Medical Device Contract Research Organization
12.3.1. Capital Expenditures (CAPEX)
12.3.2. Operational Expenditures (OPEX)
12.4. Total Cost of Ownership of Medical Devices Contract Research Organizations, 2022-2042
12.5. Total Cost of Ownership of Medical Devices Contract Research Organizations: Analysis by CAPEX and OPEX Costs, 2022 and 2042
12.5.1. Total Cost of Ownership of Medical Devices Contract Research Organizations: Analysis by CAPEX Costs, 2022-2042
12.5.2. Total Cost of Ownership of Medical Devices Contract Research Organizations: Analysis by OPEX Costs, 2022-2042
12.6. Concluding Remarks

13. SURVEY INSIGHTS
13.1. Chapter Overview
13.2. Designation of Respondents
13.3. Types of Services Offered
13.4. Target Therapeutic Area
13.5. Average Number of Annual Projects
13.6. Market Opportunity

14. MARKET SIZING AND OPPORTUNITY ANALYSIS
14.1. Chapter Overview
14.2. Assumptions and Forecast Methodology

14.3. Overall Medical Device CROs Market, 2022-2035
14.3.1. Medical Device CROs Market: Analysis by Therapeutic Area, 2022, 2028 and 2035
14.3.2. Medical Device CROs Market: Analysis by Scale of Operation, 2022-2035
14.3.3. Medical Device CROs Market: Analysis by Device Class, 2022-2035
14.3.4. Medical Device CROs Market, 2022-2035: Analysis by Type of Clinical Service Offered, 2022-2035
14.3.5. Medical Device CROs Market, 2022-2035: Analysis by Type of Preclinical Service Offered, 2022-2035
14.3.6. Medical Device CROs Market: Analysis by Geography, 2022, 2028 and 2035

14.4. Medical Device CROs Market in North America, 2022-2035
14.4.1. Medical Device CROs Market in North America: Analysis by Therapeutic Area, 2022-2035
14.4.1.1. Medical Device CROs Market for CNS Disorders in North America, 2022-2035
14.4.1.2. Medical Device CROs Market for Cardiovascular Disorders in North America, 2022-2035
14.4.1.3. Medical Device CROs Market for Oncological Disorders in North America, 2022-2035
14.4.1.4. Medical Device CROs Market for Bone Disorders in North America, 2022-2035
14.4.1.5. Medical Device CROs Market for Respiratory Disorders in North America, 2022-2035
14.4.1.6. Medical Device CROs Market for Pain Management Disorders in North America, 2022-2035
14.4.1.7. Medical Device CROs Market for Ophthalmic Disorders in North America, 2022-2035
14.4.1.8. Medical Device CROs Market for Psychological Disorders in North America, 2022-2035
14.4.1.9. Medical Device CROs Market for Metabolic Disorders in North America, 2022-2035
14.4.1.10. Medical Device CROs Market for Other Disorders in North America, 2022-2035

14.4.2. Medical Device CROs Market in North America: Analysis by Device Class, 2022-2035
14.4.2.1. Medical Device CROs Market for Class I Devices in North America, 2022-2035
14.4.2.2. Medical Device CROs Market for Class II Devices in North America, 2022-2035
14.4.2.3. Medical Device CROs Market for Class III Devices in North America, 2022-2035

14.4.3. Medical Device CROs Market in North America: Analysis by Type of Clinical Service Offered, 2022-2035
14.4.3.1. Medical Device CROs Market for Clinical Trial Management Services in North America, 2022-2035
14.4.3.2. Medical Device CROs Market for Consulting Services in North America, 2022-2035
14.4.3.3. Medical Device CROs Market for Data Management Services in North America, 2022-2035
14.4.3.4. Medical Device CROs Market for Regulatory Affairs Management Services in North America, 2022-2035
14.4.3.5. Medical Device CROs Market for Other Clinical Services in North America, 2022-2035

14.4.4. Medical Device CROs Market in North America: Analysis by Type of Preclinical Service Offered, 2022-2035
14.4.4.1. Medical Device CROs Market for Material Characterization and Analytical Services in North America, 2022-2035
14.4.4.2. Medical Device CROs Market for Biocompatibility Testing Services in North America, 2022-2035
14.4.4.3. Medical Device CROs Market for Sterility and Microbiology Testing Services in North America, 2022-2035
14.4.4.4. Medical Device CROs Market for Other Preclinical Services in North America, 2022-2035

14.5. Medical Device CROs Market in Europe, 2022-2035
14.5.1. Medical Device CROs Market in Europe: Analysis by Therapeutic Area, 2022-2035
14.5.1.1. Medical Device CROs Market for CNS Disorders in Europe, 2022-2035
14.5.1.2. Medical Device CROs Market for Cardiovascular Disorders in Europe, 2022-2035
14.5.1.3. Medical Device CROs Market for Oncological Disorders in Europe, 2022-2035
14.5.1.4. Medical Device CROs Market for Bone Disorders in Europe, 2022-2035
14.5.1.5. Medical Device CROs Market for Respiratory Disorders in Europe, 2022-2035
14.5.1.6. Medical Device CROs Market for Pain Management Disorders in Europe, 2022-2035
14.5.1.7. Medical Device CROs Market for Ophthalmic Disorders in Europe, 2022-2035
14.5.1.8. Medical Device CROs Market for Psychological Disorders in Europe, 2022-2035
14.5.1.9. Medical Device CROs Market for Metabolic Disorders in Europe, 2022-2035
14.5.1.10. Medical Device CROs Market for Other Disorders in Europe, 2022-2035

14.5.2. Medical Device CROs Market in Europe: Analysis by Device Class, 2022-2035
14.5.2.1. Medical Device CROs Market for Class I Devices in Europe, 2022-2035
14.5.2.2. Medical Device CROs Market for Class II Devices in Europe, 2022-2035
14.5.2.3. Medical Device CROs Market for Class III Devices in Europe, 2022-2035

14.5.3. Medical Device CROs Market in Europe: Analysis by Type of Clinical Service Offered, 2022-2035
14.5.3.1. Medical Device CROs Market for Clinical Trial Management Services in Europe, 2022-2035
14.5.3.2. Medical Device CROs Market for Consulting Services in Europe, 2022-2035
14.5.3.3. Medical Device CROs Market for Data Management Services in Europe, 2022-2035
14.5.3.4. Medical Device CROs Market for Regulatory Affairs Management Services in Europe, 2022-2035
14.5.3.5. Medical Device CROs Market for Other Clinical Services in Europe, 2022-2035

14.5.4. Medical Device CROs Market in Europe: Analysis by Type of Preclinical Service Offered, 2022-2035
14.5.4.1. Medical Device CROs Market for Material Characterization and Analytical Services in Europe, 2022-2035
14.5.4.2. Medical Device CROs Market for Biocompatibility Testing Services in Europe, 2022-2035
14.5.4.3. Medical Device CROs Market for Sterility and Microbiology Testing Services in Europe, 2022-2035
14.5.4.4. Medical Device CROs Market for Other Preclinical Services in Europe, 2022-2035

14.6. Medical Device CROs Market in Asia-Pacific, 2022-2035
14.6.1. Medical Device CROs Market in Asia-Pacific: Analysis by Therapeutic Area, 2022-2035
14.6.1.1. Medical Device CROs Market for CNS Disorders in Asia-Pacific, 2022-2035
14.6.1.2. Medical Device CROs Market for Cardiovascular Disorders in Asia-Pacific, 2022-2035
14.6.1.3. Medical Device CROs Market for Oncological Disorders in Asia-Pacific, 2022-2035
14.6.1.4. Medical Device CROs Market for Bone Disorders in Asia-Pacific, 2022-2035
14.6.1.5. Medical Device CROs Market for Respiratory Disorders in Asia-Pacific, 2022-2035
14.6.1.6. Medical Device CROs Market for Pain Management Disorders in Asia-Pacific, 2022-2035
14.6.1.7. Medical Device CROs Market for Ophthalmic Disorders in Asia-Pacific, 2022-2035
14.6.1.8. Medical Device CROs Market for Psychological Disorders in Asia-Pacific, 2022-2035
14.6.1.9. Medical Device CROs Market for Metabolic Disorders in Asia-Pacific, 2022-2035
14.6.1.10. Medical Device CROs Market for Other Disorders in Asia-Pacific, 2022-2035

14.6.2. Medical Device CROs Market in Asia-Pacific: Analysis by Device Class, 2022-2035
14.6.2.1. Medical Device CROs Market for Class I Devices in Asia-Pacific, 2022-2035
14.6.2.2. Medical Device CROs Market for Class II Devices in Asia-Pacific, 2022-2035
14.6.2.3. Medical Device CROs Market for Class III Devices in Asia-Pacific, 2022-2035

14.6.3. Medical Device CROs Market in Asia-Pacific: Analysis by Type of Clinical Service Offered, 2022-2035
14.6.3.1. Medical Device CROs Market for Clinical Trial Management Services in Asia-Pacific, 2022-2035
14.6.3.2. Medical Device CROs Market for Consulting Services in Asia-Pacific, 2022-2035
14.6.3.3. Medical Device CROs Market for Data Management Services in Asia-Pacific, 2022-2035
14.6.3.4. Medical Device CROs Market for Regulatory Affairs Management Services in Asia-Pacific, 2022-2035
14.6.3.5. Medical Device CROs Market for Other Clinical Services in Asia-Pacific, 2022-2035

14.6.4. Medical Device CROs Market in Asia-Pacific: Analysis by Type of Preclinical Service Offered, 2022-2035
14.6.4.1. Medical Device CROs Market for Material Characterization and Analytical Services in Asia-Pacific, 2022-2035
14.6.4.2. Medical Device CROs Market for Biocompatibility Testing Services in Asia-Pacific, 2022-2035
14.6.4.3. Medical Device CROs Market for Sterility and Microbiology Testing Services in Asia-Pacific, 2022-2035
14.6.4.4. Medical Device CROs Market for Other Preclinical Services in Asia-Pacific, 2022-2035

14.7. Medical Device CROs Market in Rest of the World, 2022-2035
14.7.1. Medical Device CROs Market in Rest of the World: Analysis by Therapeutic Area, 2022-2035
14.7.1.1. Medical Device CROs Market for CNS Disorders in Rest of the World, 2022-2035
14.7.1.2. Medical Device CROs Market for Cardiovascular Disorders in Rest of the World, 2022-2035
14.7.1.3. Medical Device CROs Market for Oncological Disorders in Rest of the World, 2022-2035
14.7.1.4. Medical Device CROs Market for Bone Disorders in Rest of the World, 2022-2035
14.7.1.5. Medical Device CROs Market for Respiratory Disorders in Rest of the World, 2022-2035
14.7.1.6. Medical Device CROs Market for Pain Management Disorders in Rest of the World, 2022-2035
14.7.1.7. Medical Device CROs Market for Ophthalmic Disorders in Rest of the World, 2022-2035
14.7.1.8. Medical Device CROs Market for Psychological Disorders in Rest of the World, 2022-2035
14.7.1.9. Medical Device CROs Market for Metabolic Disorders in Rest of the World, 2022-2035
14.7.1.10. Medical Device CROs Market for Other Disorders in Rest of the World, 2022-2035

14.7.2. Medical Device CROs Market in Rest of the World: Analysis by Device Class, 2022-2035
14.7.2.1. Medical Device CROs Market for Class I Devices in Rest of the World, 2022-2035
14.7.2.2. Medical Device CROs Market for Class II Devices in Rest of the World, 2022-2035
14.7.2.3. Medical Device CROs Market for Class III Devices in Rest of the World, 2022-2035

14.7.3. Medical Device CROs Market in Rest of the World: Analysis by Type of Clinical Service Offered, 2022-2035
14.7.3.1. Medical Device CROs Market for Clinical Trial Management Services in Rest of the World, 2022-2035
14.7.3.2. Medical Device CROs Market for Consulting Services in Rest of the World, 2022-2035
14.7.3.3. Medical Device CROs Market for Data Management Services in Rest of the World, 2022-2035
14.7.3.4. Medical Device CROs Market for Regulatory Affairs Management Services in Rest of the World, 2022-2035
14.7.3.5. Medical Device CROs Market for Other Clinical Services in Rest of the World, 2022-2035

14.7.4. Medical Device CROs Market in Rest of the World: Analysis by Type of Preclinical Service Offered, 2022-2035
14.7.4.1. Medical Device CROs Market for Material Characterization and Analytical Services in Rest of the World, 2022-2035
14.7.4.2. Medical Device CROs Market for Biocompatibility Testing Services in Rest of the World, 2022-2035
14.7.4.3. Medical Device CROs Market for Sterility and Microbiology Testing Services in Rest of the World, 2022-2035
14.7.4.4. Medical Device CROs Market for Other Preclinical Services in Rest of the World, 2022-2035

15. SWOT ANALYSIS
15.1. Chapter Overview
15.2. Strengths
15.3. Weaknesses
15.4. Opportunities
15.5. Threats
15.6. Concluding Remarks

16. FUTURE TRENDS AND OPPORTUNITIES
16.1. Chapter Overview
16.2. Anticipated Growth in Number of Connected Devices
16.3. Adoption of Data Analytics and Real-Time Monitoring Solutions
16.4. Need for Cloud-based Computing and Storage Solutions
16.5. Growing Demand for Real World Evidence to Obtain Regulatory Approval
16.6. Concluding Remarks

17. INTERVIEW TRANSCRIPTS
17.1. Chapter Overview
17.2. HungaroTrial
17.2.1. Company Snapshot
17.2.2. Interview Transcript: Lajos Sarosi, Chief Executive Officer and Co-founder
17.3. ClinChoice
17.3.1. Company Snapshot
17.3.2. Lee King, Senior Vice President of Business Development and Marketing
17.4. NAMSA
17.4.1. Company Snapshot
17.4.2. Christopher Rupp, Vice President of Global Marketing and Commercial Operations
17.5. CTC North
17.5.1. Company Snapshot
17.5.2. Claus Hemiker, Head of Business Development
17.6. CW Research & Management
17.6.1. Company Snapshot
17.6.2. Christian Wolflehner, General Manager
17.7. CROMSOURCE
17.7.1. Company Snapshot
17.7.2. Troy McCall, Chief Operating Officer
17.8. Metrics Research
17.8.1. Company Snapshot
17.8.2. Nazish Urooj, Senior manager, Medical & Clinical Operations
17.9. Vyomus Consulting
17.9.1. Company Snapshot
17.9.2. C. Omprakash, Technical Director and Partner
17.10. A+ Science
17.10.1. Company Snapshot
17.10.2. Tania Persson, Director of Business Development
17.11. AtoZ-CRO
17.11.1 Company Snapshot
17.11.2. Alexa Foltin-Mertgen, Business Development Manager

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Clinical Trial Analysis
Figure 2.3 Executive Summary: Mergers and Acquisitions
Figure 2.4 Executive Summary: Total Cost of Ownership
Figure 2.5 Executive Summary: Market Sizing and Opportunity Analysis
Figure 3.1 Historical Timeline of Medical Device Inventions
Figure 3.2 Medical Device: Development Process and Timeline
Figure 3.3 Types of CROs Engaged in the Medical Device Market
Figure 3.4 Services Offered by CROs
Figure 3.5 Risks / Challenges Associated with Outsourcing Operations to CROs
Figure 4.1 Medical Device Clinical CROs: Distribution by Year of Establishment
Figure 4.2 Medical Device Clinical CROs: Distribution by Company Size
Figure 4.3 Medical Device Clinical CROs: Distribution by Location of Headquarters
Figure 4.4 Medical Device Clinical CROs: Distribution by Company Size and Location of Headquarters
Figure 4.5 Medical Device Clinical CROs: Distribution by Area of Specialization
Figure 4.6 Medical Device Clinical CROs: Distribution by Device Class
Figure 4.7 Medical Device Clinical CROs: Distribution by Type of Clinical Operation Service Offered
Figure 4.8 Medical Device Clinical CROs: Distribution by Year of Establishment, Type of Clinical Service Offered and Geography
Figure 4.9 Medical Device Clinical CROs: Distribution by Type of Regulatory Affairs-related Service Offered
Figure 4.10 Medical Device Clinical CROs: Distribution by Type of Additional Service Offered
Figure 4.11 Medical Device Clinical CROs: Distribution by Type of Medical Device Regulatory Compliance Authority
Figure 4.12 Medical Device Preclinical CROs: Distribution by Year of Establishment
Figure 4.13 Medical Device Preclinical CROs: Distribution by Company Size
Figure 4.14 Medical Device Preclinical CROs: Distribution by Location of Headquarters
Figure 4.15 Medical Device Preclinical CROs: Distribution by Company Size and Location of Headquarters
Figure 4.16 Medical Device Preclinical CROs: Distribution by Type of Preclinical Service Offered
Figure 4.17 Medical Device Preclinical CROs: Distribution by Year of Establishment, Type of Preclinical Service Offered and Geography
Figure 4.18 Medical Device Standalone CROs: Distribution by Year of Establishment
Figure 4.19 Medical Device Standalone CROs: Distribution by Company Size
Figure 4.20 Medical Device Standalone CROs: Distribution by Location of Headquarters
Figure 4.21 Medical Device Standalone CROs: Distribution by Company Size and Location of Headquarters
Figure 5.1 Key Regulatory Authorities for Medical Devices
Figure 5.2 Medical Devices Review / Approval Process in the US
Figure 5.3 Healthcare Insurance Coverage in the US: Distribution by Type of Coverage
Figure 5.4 Medical Devices National Coverage Determination Process in the US
Figure 5.5 Medical Devices Review / Approval Process in Canada
Figure 5.6 Healthcare Insurance Coverage in Canada: Distribution by Type of Coverage
Figure 5.7 Medical Devices Review / Approval Process in Mexico
Figure 5.8 Regulatory Bodies in EU5 Countries
Figure 5.9 Steps involved in CE Marking Process
Figure 5.10 Medical Devices Review / Approval Process in Europe
Figure 5.11 Medical Devices Review / Approval Process in the UK
Figure 5.12 Healthcare Insurance Coverage in the UK: Distribution by Type of Coverage
Figure 5.13 Reimbursement Process for Medical Devices in the UK
Figure 5.14 Healthcare Insurance Coverage in France: Distribution by Type of Coverage
Figure 5.15 Reimbursement Process for Medical Devices through List of Products and Services Qualifying for Reimbursement
Figure 5.16 Healthcare Insurance Coverage in Germany: Distribution by Type of Coverage
Figure 5.17 Reimbursement Process for In-Patient Setting in Germany
Figure 5.18 Reimbursement Process for Out-Patient Care in Germany
Figure 5.19 Healthcare Insurance Coverage in Italy: Distribution by Type of Coverage
Figure 5.20 Reimbursement Process for Medical Devices in Italy
Figure 5.21 Healthcare Insurance Coverage in Spain: Distribution by Type of Coverage
Figure 5.22 Reimbursement Process for Medical Devices in Spain
Figure 5.23 Medical Devices Review / Approval Process in Australia
Figure 5.24 Healthcare Insurance Coverage in Australia: Distribution by Type of Coverage
Figure 5.25 Medical Devices Review / Approval Process in Brazil
Figure 5.26 Reimbursement Process for Medical Devices in Brazil
Figure 5.27 Medical Devices Review / Approval Process in China
Figure 5.28 Healthcare Insurance Coverage in China: Distribution by Type of Coverage
Figure 5.29 Reimbursement Approval Process for Medical Devices in Shanghai
Figure 5.30 Medical Devices Review / Approval Process in India
Figure 5.31 Healthcare Insurance Coverage in Israel: Distribution by Type of Coverage
Figure 5.32 Medical Devices Review / Approval Process in Japan
Figure 5.33 Snapshot of the Regulatory and Reimbursement Process in Japan
Figure 5.34 Healthcare Insurance Coverage in Japan: Distribution by Type of Coverage
Figure 5.35 Reimbursement Process for New Medical Devices in Japan
Figure 5.36 Medical Devices Review / Approval Process in New Zealand
Figure 5.37 Healthcare Insurance Coverage in New Zealand: Distribution by Type of Coverage
Figure 5.38 Medical Devices Review / Approval Process in Singapore
Figure 5.39 Medical Devices Review / Approval Process in South Korea
Figure 5.40 Healthcare Insurance Coverage in South Korea: Distribution by Type of Coverage
Figure 5.41 Medical Devices Review / Approval Process in South Africa
Figure 5.42 Medical Devices Review / Approval Process in Taiwan
Figure 5.43 Healthcare Insurance Coverage in Taiwan: Distribution by Type of Coverage
Figure 5.44 Medical Devices Review / Approval Process in Thailand
Figure 5.45 Heat Map Analysis: Comparison of Regional Regulatory Control for Medical Devices
Figure 5.46 Regulatory Control for Medical Devices: Regional Distribution by Device Risk Category
Figure 6.1 Avania: Service Portfolio
Figure 6.2 Charles River Laboratories: Service Portfolio
Figure 6.3 CROMSOURCE: Service Portfolio
Figure 6.4 CSSi LifeSciences: Service Portfolio
Figure 6.5 Eurofins Medical Device Testing: Preclinical Service Portfolio
Figure 6.6 Eurofins Medical Device Testing: Clinical Service Portfolio
Figure 6.7 IQVIA: Service Portfolio
Figure 6.8 Medpace: Service Portfolio
Figure 6.9 NAMSA: Service Portfolio
Figure 6.10 Qserve Group: Service Portfolio
Figure 6.11 WuXi AppTec: Preclinical Service Portfolio
Figure 6.12 WuXi AppTec: Clinical Service Portfolio
Figure 7.1 Key Attributes for Selection of Key Performance Indicators (KPIs)
Figure 7.2 Types of KPIs
Figure 7.3 Financial Indicators: Comparative Analysis of KPIs considered by Big Pharma Companies
Figure 7.4 Financial Indicators: Sponsors’ (Big Pharma) Perspective
Figure 7.5 Financial Indicators: Contract Service Providers’ Perspective
Figure 7.6 Process / Capability Indicators: Comparative Analysis of KPIs considered by Big Pharma Companies
Figure 7.7 Process / Capability Indicators: Sponsors’ (Big Pharma) Perspective
Figure 7.8 Process / Capability Indicators: Contract Service Providers’ Perspective
Figure 7.9 Market Reputation Indicators: Comparative Analysis of KPIs considered by Big Pharma Companies
Figure 7.10 Market Reputation Indicators: Sponsors’ (Big Pharma) Perspective
Figure 7.11 Market Reputation Indicators: Contract Service Providers’ Perspective
Figure 7.12 Comparison of Key Factors to be considered while selecting KPIs for Medical Devices
Figure 8.1 Competitive Benchmarking: Distribution by Region and Company Size
Figure 8.2 Competitive Benchmarking: Small Players based in North America (Peer Group I)
Figure 8.3 Competitive Benchmarking: Mid-sized Players based in North America (Peer Group II)
Figure 8.4 Competitive Benchmarking: Large Players based in North America (Peer Group III)
Figure 8.5 Competitive Benchmarking: Small Players based in Europe (Peer Group IV)
Figure 8.6 Competitive Benchmarking: Mid-sized Players based in Europe (Peer Group V)
Figure 8.7 Competitive Benchmarking: Large Players based in Europe (Peer Group VI)
Figure 8.8 Competitive Benchmarking: Small Players based in Asia-Pacific (Peer Group VII)
Figure 8.9 Competitive Benchmarking: Mid-sized Players based in Asia-Pacific (Peer Group VIII)
Figure 8.10 Competitive Benchmarking: Large Players based in Asia-Pacific (Peer Group IX)
Figure 8.11 Competitive Benchmarking: Small Players based in Rest of the World (Peer Group X)
Figure 8.12 Competitive Benchmarking: Mid-sized Players based in Rest of the World (Peer Group XI)
Figure 8.13 Competitive Benchmarking Summary
Figure 9.1 Brand Positioning of Key Industry Players: Unfair Advantage
Figure 9.2 Brand Positioning of Key Industry Players: Reasons to Believe
Figure 9.3 Brand Positioning Matrix: Labcorp
Figure 9.4 Brand Positioning Matrix: IQVIA
Figure 9.5 Brand Positioning Matrix: Syneos Health
Figure 9.6 Brand Positioning Matrix: PPD
Figure 9.7 Brand Positioning Matrix: ICON
Figure 9.8 Brand Positioning Matrix: Charles River Laboratories
Figure 9.9 Brand Positioning Matrix: WuXi AppTec
Figure 9.10 Brand Positioning Matrix: Medpace
Figure 10.1 Clinical Trial Analysis: Distribution by Trial Registration Year, 2015-2022
Figure 10.2 Clinical Trial Analysis: Distribution by Trial Status
Figure 10.3 Clinical Trial Analysis: Distribution by Phase of Development
Figure 10.4 Clinical Trial Analysis: Distribution by Study Design
Figure 10.5 Clinical Trial Analysis: Distribution by Therapeutic Area
Figure 10.6 Clinical Trial Analysis: Distribution by Geography
Figure 10.7 Clinical Trial Analysis: Distribution by Trial Registration Year and Geography
Figure 10.8 Clinical Trial Analysis: Distribution by Trial Status and Geography
Figure 10.9 Clinical Trial Analysis: Distribution by Type of Sponsor
Figure 10.10 Most Active Players: Distribution by Number of Clinical Trials
Figure 10.11 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Trial Registration Year
Figure 10.12 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Phase of Development
Figure 10.13 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Geography
Figure 10.14 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Trial Status and Geography
Figure 11.1 Mergers and Acquisitions: Cumulative Year-Wise Trend (2015-2022)
Figure 11.2 Mergers and Acquisitions: Distribution by Type of Agreement
Figure 11.3 Mergers and Acquisitions: Distribution by Year and Type of Agreement
Figure 11.4 Mergers and Acquisitions: Continent-wise Distribution
Figure 11.5 Mergers and Acquisitions: Intercontinental and Intracontinental Acquisitions
Figure 11.6 Mergers and Acquisitions: Country-wise Distribution
Figure 11.7 Mergers and Acquisitions: Ownership Change Matrix
Figure 11.8 Mergers and Acquisitions: Distribution by Type of Company
Figure 11.9 Mergers and Acquisitions: Distribution by Key Value Drivers
Figure 11.10 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Figure 12.1 Total Cost of Ownership: Capital Expenditures (CAPEX)
Figure 12.2 Total Cost of Ownership: Operational Expenditures (OPEX)
Figure 12.3 Total Cost of Ownership of Medical Devices Contract Research Organizations, 2022-2042 (USD Million)
Figure 12.4 Total Cost of Ownership of Medical Devices Contract Research Organizations: Distribution by CAPEX and OPEX Costs, 2022 and 2042 (USD Million)
Figure 12.5 Total Cost of Ownership of Medical Devices Contract Research Organizations: Distribution by CAPEX Costs, 2022-2042 (USD Million)
Figure 12.6 Total Cost of Ownership of Medical Devices Contract Research Organizations: Distribution by OPEX Costs, 2022-2042 (USD Million)
Figure 13.1 Survey Insights: Distribution of Respondents by Designation and Seniority Level
Figure 13.2 Survey Insights: Distribution of Respondents by Type of Service Offered
Figure 13.3 Survey Insights: Distribution of Respondents by Therapeutic Area
Figure 13.4 Survey Insights: Distribution of Respondents by Average Number of Annual Projects
Figure 13.5 Survey Insights: Distribution of Respondents by Market Opportunity
Figure 14.1 Overall Medical Device CROs Market, 2022-2035 (USD Billion)
Figure 14.2 Medical Device CROs Market, 2022, 2028 and 2035: Distribution by Therapeutic Area (USD Billion)
Figure 14.3 Medical Device CROs Market, 2022-2035: Distribution by Scale of Operation (USD Billion)
Figure 14.4 Medical Device CROs Market, 2022-2035: Distribution by Device Class (USD Billion)
Figure 14.5 Medical Device CROs Market, 2022-2035: Distribution by Type of Clinical Service Offered (USD Billion)
Figure 14.6 Medical Device CROs Market, 2022-2035: Distribution by Type of Preclinical Service Offered (USD Billion)
Figure 14.7 Medical Device CROs Market, 2022, 2028 and 2035: Distribution by Geography (USD Billion)
Figure 14.8 Medical Device CROs Market in North America, 2022-2035 (USD Billion)
Figure 14.9 Medical Device CROs Market for CNS Disorders in North America, 2022-2035 (USD Billion)
Figure 14.10 Medical Device CROs Market for Cardiovascular Disorders in North America, 2022-2035 (USD Billion)
Figure 14.11 Medical Device CROs Market for Oncological Disorders in North America, 2022-2035 (USD Billion)
Figure 14.12 Medical Device CROs Market for Bone Disorders in North America, 2022-2035 (USD Billion)
Figure 14.13 Medical Device CROs Market for Respiratory Disorders in North America, 2022-2035 (USD Billion)
Figure 14.14 Medical Device CROs Market for Pain Disorders in North America, 2022-2035 (USD Billion)
Figure 14.15 Medical Device CROs Market for Ophthalmic Disorders in North America, 2022-2035 (USD Billion)
Figure 14.16 Medical Device CROs Market for Psychological Disorders in North America, 2022-2035 (USD Billion)
Figure 14.17 Medical Device CROs Market for Metabolic Disorders in North America, 2022-2035 (USD Billion)
Figure 14.18 Medical Device CROs Market for Other Disorders in North America, 2022-2035 (USD Billion)
Figure 14.19 Medical Device CROs Market for Class I Devices in North America, 2022-2035 (USD Billion)
Figure 14.20 Medical Device CROs Market for Class II Devices in North America, 2022-2035 (USD Billion)
Figure 14.21 Medical Device CROs Market for Class III Devices in North America, 2022-2035 (USD Billion)
Figure 14.22 Medical Device CROs Market for Clinical Trial Management Services in North America, 2022-2035 (USD Billion)
Figure 14.23 Medical Device CROs Market for Consulting Services in North America, 2022-2035 (USD Billion)
Figure 14.24 Medical Device CROs Market for Data Management Services in North America, 2022-2035 (USD Billion)
Figure 14.25 Medical Device CROs Market for Regulatory Affairs Management Services in North America, 2022-2035 (USD Billion)
Figure 14.26 Medical Device CROs Market for Other Clinical Services in North America, 2022-2035 (USD Billion)
Figure 14.27 Medical Device CROs Market for Material Characterization and Analytical Services in North America, 2022-2035 (USD Billion)
Figure 14.28 Medical Device CROs Market for Biocompatibility Testing Services in North America, 2022-2035 (USD Billion)
Figure 14.29 Medical Device CROs Market for Sterility and Microbiology Testing Services in North America, 2022-2035 (USD Billion)
Figure 14.30 Medical Device CROs Market for Other Preclinical Services in North America, 2022-2035 (USD Billion)
Figure 14.31 Medical Device CROs Market in Europe, 2022-2035 (USD Billion)
Figure 14.32 Medical Device CROs Market for CNS Disorders in Europe, 2022-2035 (USD Billion)
Figure 14.33 Medical Device CROs Market for Cardiovascular Disorders in Europe, 2022-2035 (USD Billion)
Figure 14.34 Medical Device CROs Market for Oncological Disorders in Europe, 2022-2035 (USD Billion)
Figure 14.35 Medical Device CROs Market for Bone Disorders in Europe, 2022-2035 (USD Billion)
Figure 14.36 Medical Device CROs Market for Respiratory Disorders in Europe, 2022-2035 (USD Billion)
Figure 14.37 Medical Device CROs Market for Pain Disorders in Europe, 2022-2035 (USD Billion)
Figure 14.38 Medical Device CROs Market for Ophthalmic Disorders in Europe, 2022-2035 (USD Billion)
Figure 14.39 Medical Device CROs Market for Psychological Disorders in Europe, 2022-2035 (USD Billion)
Figure 14.40 Medical Device CROs Market for Metabolic Disorders in Europe, 2022-2035 (USD Billion)
Figure 14.41 Medical Device CROs Market for Other Disorders in Europe, 2022-2035 (USD Billion)
Figure 14.42 Medical Device CROs Market for Class I Devices in Europe, 2022-2035 (USD Billion)
Figure 14.43 Medical Device CROs Market for Class II Devices in Europe, 2022-2035 (USD Billion)
Figure 14.44 Medical Device CROs Market for Class III Devices in Europe, 2022-2035 (USD Billion)
Figure 14.45 Medical Device CROs Market for Clinical Trial Management Services in Europe, 2022-2035 (USD Billion)
Figure 14.46 Medical Device CROs Market for Consulting Services in Europe, 2022-2035 (USD Billion)
Figure 14.47 Medical Device CROs Market for Data Management Services in Europe, 2022-2035 (USD Billion)
Figure 14.48 Medical Device CROs Market for Regulatory Affairs Management Services in Europe, 2022-2035 (USD Billion)
Figure 14.49 Medical Device CROs Market for Other Clinical Services in Europe, 2022-2035 (USD Billion)
Figure 14.50 Medical Device CROs Market for Material Characterization and Analytical Services in Europe, 2022-2035 (USD Billion)
Figure 14.51 Medical Device CROs Market for Biocompatibility Testing Services in Europe, 2022-2035 (USD Billion)
Figure 14.52 Medical Device CROs Market for Sterility and Microbiology Testing Services in Europe, 2022-2035 (USD Billion)
Figure 14.53 Medical Device CROs Market for Other Preclinical Services in Europe, 2022-2035 (USD Billion)
Figure 14.54 Medical Device CROs Market in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.55 Medical Device CROs Market for CNS Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.56 Medical Device CROs Market for Cardiovascular Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.57 Medical Device CROs Market for Oncological Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.58 Medical Device CROs Market for Bone Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.59 Medical Device CROs Market for Respiratory Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.60 Medical Device CROs Market for Pain Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.61 Medical Device CROs Market for Ophthalmic Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.62 Medical Device CROs Market for Psychological Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.63 Medical Device CROs Market for Metabolic Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.64 Medical Device CROs Market for Other Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.65 Medical Device CROs Market for Class I Devices in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.66 Medical Device CROs Market for Class II Devices in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.67 Medical Device CROs Market for Class III Devices in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.68 Medical Device CROs Market for Clinical Trial Management Services in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.69 Medical Device CROs Market for Consulting Services in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.70 Medical Device CROs Market for Data Management Services in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.71 Medical Device CROs Market for Regulatory Affairs Management Services in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.72 Medical Device CROs Market for Other Clinical Services in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.73 Medical Device CROs Market for Material Characterization and Analytical Services in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.74 Medical Device CROs Market for Biocompatibility Testing Services in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.75 Medical Device CROs Market for Sterility and Microbiology Testing Services in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.76 Medical Device CROs Market for Other Preclinical Services in Asia-Pacific, 2022-2035 (USD Billion)
Figure 14.77 Medical Device CROs Market in Rest of the World, 2022-2035 (USD Billion)
Figure 14.78 Medical Device CRO Market for CNS Disorders in Rest of the World, 2022-2035 (USD Billion)
Figure 14.79 Medical Device CROs Market for Cardiovascular Disorders in Rest of the World, 2022-2035 (USD Billion)
Figure 14.80 Medical Device CROs Market for Oncological Disorders in Rest of the World, 2022-2035 (USD Billion)
Figure 14.81 Medical Device CROs Market for Bone Disorders in Rest of the World, 2022-2035 (USD Billion)
Figure 14.82 Medical Device CROs Market for Respiratory Disorders in Rest of the World, 2022-2035 (USD Billion)
Figure 14.83 Medical Device CROs Market for Pain Disorders in Rest of the World, 2022-2035 (USD Billion)
Figure 14.84 Medical Device CROs Market for Ophthalmic Disorders in Rest of the World, 2022-2035 (USD Billion)
Figure 14.85 Medical Device CROs Market for Psychological Disorders in Rest of the World, 2022-2035 (USD Billion)
Figure 14.86 Medical Device CROs Market for Metabolic Disorders in Rest of the World, 2022-2035 (USD Billion)
Figure 14.87 Medical Device CROs Market for Other Disorders in Rest of the World, 2022-2035 (USD Billion)
Figure 14.88 Medical Device CROs Market for Class I Devices in Rest of the World, 2022-2035 (USD Billion)
Figure 14.89 Medical Device CROs Market for Class II Devices in Rest of the World, 2022-2035 (USD Billion)
Figure 14.90 Medical Device CROs Market for Class III Devices in Rest of the World, 2022-2035 (USD Billion)
Figure 14.91 Medical Device CROs Market for Clinical Trial Management Services in Rest of the World, 2022-2035 (USD Billion)
Figure 14.92 Medical Device CROs Market for Consulting Services in Rest of the World, 2022-2035 (USD Billion)
Figure 14.93 Medical Device CROs Market for Data Management Services in Rest of the World, 2022-2035 (USD Billion)
Figure 14.94 Medical Device CROs Market for Regulatory Affairs Management Services in Rest of the World, 2022-2035 (USD Billion)
Figure 14.95 Medical Device CROs Market for Other Clinical Services in Rest of the World, 2022-2035 (USD Billion)
Figure 14.96 Medical Device CROs Market for Material Characterization and Analytical Services in Rest of the World, 2022-2035 (USD Billion)
Figure 14.97 Medical Device CROs Market for Biocompatibility Testing Services in Rest of the World, 2022-2035 (USD Billion)
Figure 14.98 Medical Device CROs Market for Sterility and Microbiology Testing Services in Rest of the World, 2022-2035 (USD Billion)
Figure 14.99 Medical Device CROs Market for Other Preclinical Services in Rest of the World, 2022-2035 (USD Billion)
Figure 15.1 Medical Device CROs Market: SWOT Analysis
Figure 15.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 16.1 Future Trends and Opportunities for Medical Device CROs

List Of Tables

Table 3.1 Comparison of Key Factors Considered by Medical Device Developers While Selecting a CRO Partner: Harvey Ball Analysis
Table 4.1 Medical Device CROs: List of Clinical Service Providers
Table 4.2 Medical Device Clinical CROs: Information on Device Class
Table 4.3 Medical Device Clinical CROs: Information on Type of Clinical Operation Service Offered
Table 4.4 Medical Device Clinical CROs: Information on Type of Regulatory Affairs-Related Service Offered
Table 4.5 Medical Device Clinical CROs: Information on Additional Service Offered
Table 4.6 Medical Device Clinical CROs: Information on Medical Device Regulatory Compliance Authorities
Table 4.7 Medical Device CROs: List of Preclinical Service Providers
Table 4.8 Medical Device Preclinical CROs: Information on Type of Preclinical Services Offered
Table 4.9 Medical Device CROs: List of Standalone Service Providers
Table 5.1 General Guidelines for Market Authorization and Reimbursement for Medical Devices
Table 5.2 Device Classification: US
Table 5.3 Device Classification: Canada
Table 5.4 Data Requirements and Characteristics of Province-wide HTA Processes in Canada
Table 5.5 Device Classification: Mexico
Table 5.6 Device Classification: Europe
Table 5.7 List of CE Directives in Europe
Table 5.8 Conformity Assessment Modules in Europe
Table 5.9 Device Classification: Australia
Table 5.10 Reimbursement and Pricing Approval Process of Medical devices in Australia
Table 5.11 Device Classification: Brazil
Table 5.12 Device Classification: China
Table 5.13 Device Classification: India
Table 5.14 Device Classification: Japan
Table 5.15 Medical Devices Reimbursement Categories
Table 5.16 Device Classification: New Zealand
Table 5.17 Device Classification: Singapore
Table 5.18 Device Classification: South Korea
Table 5.19 Device Classification: South Africa
Table 5.20 Device Classification: Thailand
Table 5.21 Medical Devices Regulatory Landscape Summary
Table 5.22 Medical Devices Reimbursement Landscape Summary
Table 6.1 Avania: Company Overview
Table 6.2 Avania: Recent Developments and Future Outlook
Table 6.3 Charles River Laboratories: Company Overview
Table 6.4 Charles River Laboratories: Recent Developments and Future Outlook
Table 6.5 CROMSOURCE: Company Overview
Table 6.6 CROMSOURCE: Recent Development and Future Outlook
Table 6.7 CSSi LifeSciences: Company Overview
Table 6.8 Eurofins Medical Device Testing: Company Overview
Table 6.9 Eurofins Medical Device Testing: Recent Development and Future Outlook
Table 6.10 IQVIA: Company Overview
Table 6.11 IQVIA: Recent Development and Future Outlook
Table 6.12 Medpace: Company Overview
Table 6.13 Medpace: Recent Development and Future Outlook
Table 6.14 NAMSA: Company Overview
Table 6.15 NAMSA: Recent Development and Future Outlook
Table 6.16 Qserve Group: Company Overview
Table 6.17 Qserve Group: Recent Development and Future Outlook
Table 6.18 WuXi AppTec: Company Overview
Table 6.19 WuXi AppTec: Recent Development and Future Outlook
Table 8.1 Competitive Benchmarking Analysis: Peer Groups Definitions and Inclusions
Table 11.1 Medical Device CRO Market: List of Mergers and Acquisitions, 2015-2022
Table 11.2 Acquisitions: Key Value Drivers
Table 13.1 Survey Insights: Overview of Respondents
Table 13.2 Survey Insights: Designation and Seniority Level of Respondents
Table 13.3 Survey Insights: Information on Type of Service Offered
Table 13.4 Survey Insights: Information on Target Therapeutic Area
Table 13.5 Survey Insights: Information on Average Number of Projects
Table 13.6 Survey Insights: Information on Market Opportunity
Table 14.1 Key Assumptions
Table 18.1 Medical Device Clinical CROs: Distribution by Year of Establishment
Table 18.2 Medical Device Clinical CROs: Distribution by Company Size
Table 18.3 Medical Device Clinical CROs: Distribution by Location of Headquarters
Table 18.4 Medical Device Clinical CROs: Distribution by Company Size and Location of Headquarters
Table 18.5 Medical Device Clinical CROs: Distribution by Area of Specialization
Table 18.6 Medical Device Clinical CROs: Distribution by Device Class
Table 18.7 Medical Device Clinical CROs: Distribution by Type of Clinical Operation Services Offered
Table 18.8 Medical Device Clinical CROs: Distribution by Distribution by Year of Establishment, Type of Clinical Services Offered, and Geography
Table 18.9 Medical Device Clinical CROs: Distribution by Type of Regulatory Affairs Related Services Offered
Table 18.10 Medical Device Clinical CROs: Distribution by Type of Additional Services Offered
Table 18.11 Medical Device Clinical CROs: Distribution by Type of Medical Device Regulatory Compliance Authorities
Table 18.12 Medical Device Preclinical CROs: Distribution by Year of Establishment
Table 18.13 Medical Device Preclinical CROs: Distribution by Company Size
Table 18.14 Medical Device Preclinical CROs: Distribution by Location of Headquarters
Table 18.15 Medical Device Preclinical CROs: Distribution by Company Size and Location of Headquarters
Table 18.16 Medical Device Preclinical CROs: Distribution by Type of Preclinical Services Offered
Table 18.17 Medical Device Preclinical CROs: Distribution by Year of Establishment, Type of Preclinical Services Offered, and Geography
Table 18.18 Medical Device Standalone CROs: Distribution by Year of Establishment
Table 18.19 Medical Device Standalone CROs: Distribution by Company Size
Table 18.20 Medical Device Standalone CROs: Distribution by Location of Headquarters
Table 18.21 Medical Device Standalone CROs: Distribution by Company Size and Location of Headquarters
Table 18.22 Competitive Benchmarking: Distribution by Region and Company Size
Table 18.23 Competitive Benchmarking: Small Players based in North America (Peer Group I)
Table 18.24 Competitive Benchmarking: Mid-sized Players based in North America (Peer Group II)
Table 18.25 Competitive Benchmarking: Large Players based in North America (Peer Group III)
Table 18.26 Competitive Benchmarking: Small Players based in Europe (Peer Group IV)
Table 18.27 Competitive Benchmarking: Mid-sized Players based in Europe (Peer Group V)
Table 18.28 Competitive Benchmarking: Large Players based in Europe (Peer Group VI)
Table 18.29 Competitive Benchmarking: Small Players based in Asia-Pacific (Peer Group VII)
Table 18.30 Competitive Benchmarking: Mid-sized Players based in Asia-Pacific (Peer Group VIII)
Table 18.31 Competitive Benchmarking: Large Players based in Asia-Pacific (Peer Group IX)
Table 18.32 Competitive Benchmarking: Small Players based in Rest of the World (Peer Group X)
Table 18.33 Competitive Benchmarking: Mid-sized Players based in Rest of the World (Peer Group XI)
Table 18.34 Brand Positioning of Key Industry Players: Unfair Advantage
Table 18.35 Brand Positioning of Key Industry Players: Reasons to Believe
Table 18.36 Brand Positioning Matrix: Labcorp
Table 18.37 Brand Positioning Matrix: IQVIA
Table 18.38 Brand Positioning Matrix: Syneos Health
Table 18.39 Brand Positioning Matrix: PPD
Table 18.40 Brand Positioning Matrix: ICON
Table 18.41 Brand Positioning Matrix: Charles River Laboratories
Table 18.42 Brand Positioning Matrix: WuXi AppTec
Table 18.43 Brand Positioning Matrix: Medpace
Table 18.44 Clinical Trial Analysis: Distribution by Trial Registration Year, 2015-2022
Table 18.45 Clinical Trial Analysis: Distribution by Trial Status
Table 18.46 Clinical Trial Analysis: Distribution by Phase of Development
Table 18.47 Clinical Trial Analysis: Distribution by Study Design
Table 18.48 Clinical Trial Analysis: Distribution by Therapeutic Area
Table 18.49 Clinical Trial Analysis: Distribution by Geography
Table 18.50 Clinical Trial Analysis: Distribution by Trial Registration Year and Geography
Table 18.51 Clinical Trial Analysis: Distribution by Trial Status and Geography
Table 18.52 Clinical Trial Analysis: Distribution by Type of Sponsor
Table 18.53 Most Active Players: Distribution by Number of clinical Trials
Table 18.54 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Trial Registration Year
Table 18.55 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Phase of Development
Table 18.56 Clinical Trial Analysis: Distribution of Enrolled Patient Population by Geography
Table 18.57 Clinical Trial Analysis: Distribution of Enrolled Patient Population Trial Status and Geography
Table 18.58 Mergers and Acquisitions: Cumulative Year-Wise Trend (2015-2022)
Table 18.59 Mergers and Acquisitions: Distribution by Type of Agreement
Table 18.60 Mergers and Acquisitions: Distribution by Year and Type of Agreement
Table 18.61 Mergers and Acquisitions: Continent-wise Distribution
Table 18.62 Mergers and Acquisitions: Intercontinental and Intracontinental Acquisitions
Table 18.63 Mergers and Acquisitions: Country-wise Distribution
Table 18.64 Mergers and Acquisitions: Ownership Change Matrix
Table 18.65 Mergers and Acquisitions: Distribution by Type of Company
Table 18.66 Mergers and Acquisitions: Distribution by Key Value Drivers
Table 18.67 Mergers and Acquisitions: Distribution by Key Value Drivers and Year of Acquisition
Table 18.68 Total Cost of Ownership: Capital Expenditures (CAPEX)
Table 18.69 Total Cost of Ownership: Operational Expenditures (OPEX)
Table 18.70 Total Cost of ownership in Medical Devices Contract Research Organization, 2022-2042 (USD Million)
Table 18.71 Total Cost of Ownership of Medical Devices Contract Research Organization: Distribution by CAPEX and OPEX, 2022 and 2042 (USD Million)
Table 18.72 Total Cost of Ownership in Medical Devices Contract Research Organization, 2022: Distribution by CAPEX (USD Million)
Table 18.73 Total Cost of Ownership in Medical Devices Contract Research Organization, 2022-2042: Distribution by OPEX (USD Million)
Table 18.74 Survey Insights: Distribution of Respondents by Designation and Seniority Level
Table 18.75 Survey Insights: Distribution of Respondents by Type of Service Offered
Table 18.76 Survey Insights: Distribution of Respondents by Therapeutic Area
Table 18.77 Survey Insights: Distribution of Respondents by Average Number of Projects
Table 18.78 Survey Insights: Distribution of Respondents by Market Opportunity
Table 18.79 Overall Medical Device CROs Market, 2022-2035 (USD Billion)
Table 18.80 Medical Device CROs Market, 2022, 2028 and 2035: Distribution by Therapeutic Area (USD Billion)
Table 18.81 Medical Device CROs Market, 2022-2035: Distribution by Scale of Operation (USD Billion)
Table 18.82 Medical Device CROs Market, 2022-2035: Distribution by Device Class (USD Billion)
Table 18.83 Medical Device CROs Market, 2022-2035: Distribution by Type of Clinical Service Offered (USD Billion)
Table 18.84 Medical Device CROs Market, 2022-2035: Distribution by Type of Preclinical Service Offered (USD Billion)
Table 18.85 Medical Device CROs Market, 2022, 2028 and 2035: Distribution by Geography (USD Billion)
Table 18.86 Medical Device CROs Market in North America, 2022-2035 (USD Billion)
Table 18.87 Medical Device CROs Market for CNS Disorders in North America, 2022-2035 (USD Billion)
Table 18.88 Medical Device CROs Market for Cardiovascular Disorders in North America, 2022-2035 (USD Billion)
Table 18.89 Medical Device CROs Market for Oncological Disorders in North America, 2022-2035 (USD Billion)
Table 18.90 Medical Device CROs Market for Bone Disorders in North America, 2022-2035 (USD Billion)
Table 18.91 Medical Device CROs Market for Respiratory Disorders in North America, 2022-2035 (USD Billion)
Table 18.92 Medical Device CROs Market for Pain Disorders in North America, 2022-2035 (USD Billion)
Table 18.93 Medical Device CROs Market for Ophthalmic Disorders in North America, 2022-2035 (USD Billion)
Table 18.94 Medical Device CROs Market for Psychological Disorders in North America, 2022-2035 (USD Billion)
Table 18.95 Medical Device CROs Market for Metabolic Disorders in North America, 2022-2035 (USD Billion)
Table 18.96 Medical Device CROs Market for Other Therapeutic Areas in North America, 2022-2035 (USD Billion)
Table 18.97 Medical Device CROs Market for Class I Devices in North America, 2022-2035 (USD Billion)
Table 18.98 Medical Device CROs Market for Class II Devices in North America, 2022-2035 (USD Billion)
Table 18.99 Medical Device CROs Market for Class III Devices in North America, 2022-2035 (USD Billion)
Table 18.100 Medical Device CROs Market for Clinical Trial Management Services in North America, 2022-2035 (USD Billion)
Table 18.101 Medical Device CROs Market for Consulting Services in North America, 2022-2035 (USD Billion)
Table 18.102 Medical Device CROs Market for Data Management Services in North America, 2022-2035 (USD Billion)
Table 18.103 Medical Device CROs Market for Regulatory Affairs Management Services in North America, 2022-2035 (USD Billion)
Table 18.104 Medical Device CROs Market for Other Clinical Services in North America, 2022-2035 (USD Billion)
Table 18.105 Medical Device CROs Market for Material Characterization and Analytical Services in North America, 2022-2035 (USD Billion)
Table 18.106 Medical Device CROs Market for Biocompatibility Testing Services in North America, 2022-2035 (USD Billion)
Table 18.107 Medical Device CROs Market for Sterility and Microbiology Testing Services in North America, 2022-2035 (USD Billion)
Table 18.108 Medical Device CROs Market for Other Preclinical Services in North America, 2022-2035 (USD Billion)
Table 18.109 Medical Device CROs Market in Europe, 2022-2035 (USD Billion)
Table 18.110 Medical Device CROs Market for CNS Disorders in Europe, 2022-2035 (USD Billion)
Table 18.111 Medical Device CROs Market for Cardiovascular Disorders in Europe, 2022-2035 (USD Billion)
Table 18.112 Medical Device CROs Market for Oncological Disorders in Europe, 2022-2035 (USD Billion)
Table 18.113 Medical Device CROs Market for Bone Disorders in Europe, 2022-2035 (USD Billion)
Table 18.114 Medical Device CROs Market for Respiratory Disorders in Europe, 2022-2035 (USD Billion)
Table 18.115 Medical Device CROs Market for Pain Disorders in Europe, 2022-2035 (USD Billion)
Table 18.116 Medical Device CROs Market for Ophthalmic Disorders in Europe, 2022-2035 (USD Billion)
Table 18.117 Medical Device CROs Market for Psychological Disorders in Europe, 2022-2035 (USD Billion)
Table 18.118 Medical Device CROs Market for Metabolic Disorders in Europe, 2022-2035 (USD Billion)
Table 18.119 Medical Device CROs Market for Other Therapeutic Areas in Europe, 2022-2035 (USD Billion)
Table 18.120 Medical Device CROs Market for Class I Devices in Europe, 2022-2035 (USD Billion)
Table 18.121 Medical Device CROs Market for Class II Devices in Europe, 2022-2035 (USD Billion)
Table 18.122 Medical Device CROs Market for Class III Devices in Europe, 2022-2035 (USD Billion)
Table 18.123 Medical Device CROs Market for Clinical Trial Management Services in Europe, 2022-2035 (USD Billion)
Table 18.124 Medical Device CROs Market for Consulting Services in Europe, 2022-2035 (USD Billion)
Table 18.125 Medical Device CROs Market for Data Management Services in Europe, 2022-2035 (USD Billion)
Table 18.126 Medical Device CROs Market for Regulatory Affairs Management Services in Europe, 2022-2035 (USD Billion)
Table 18.127 Medical Device CROs Market for Other Clinical Services in Europe, 2022-2035 (USD Billion)
Table 18.128 Medical Device CROs Market for Material Characterization and Analytical Services in Europe, 2022-2035 (USD Billion)
Table 18.129 Medical Device CROs Market for Biocompatibility Testing Services in Europe, 2022-2035 (USD Billion)
Table 18.130 Medical Device CROs Market for Sterility and Microbiology Testing Services in Europe, 2022-2035 (USD Billion)
Table 18.131 Medical Device CROs Market for Other Preclinical Services in Europe, 2022-2035 (USD Billion)
Table 18.132 Medical Device CROs Market in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.133 Medical Device CROs Market for CNS Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.134 Medical Device CROs Market for Cardiovascular Disorders in Asia-Pacific,2022-2035 (USD Billion)
Table 18.135 Medical Device CROs Market for Oncological Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.136 Medical Device CROs Market for Bone Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.137 Medical Device CROs Market for Respiratory Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.138 Medical Device CROs Market for Pain Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.139 Medical Device CROs Market for Ophthalmic Disorders in Asia-Pacific, 2035-2035 (USD Billion)
Table 18.140 Medical Device CROs Market for Psychological Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.141 Medical Device CROs Market for Metabolic Disorders in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.142 Medical Device CROs Market for Other Therapeutic Areas in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.143 Medical Device CROs Market for Class I Devices in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.144 Medical Device CROs Market for Class II Devices in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.145 Medical Device CROs Market for Class III Devices in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.146 Medical Device CROs Market for Clinical Trial Management Services in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.147 Medical Device CROs Market for Consulting Services in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.148 Medical Device CROs Market for Data Management Services in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.149 Medical Device CROs Market for Regulatory Affairs Management Services in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.150 Medical Device CROs Market for Other Clinical Services in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.151 Medical Device CROs Market for Material Characterization and Analytical Services in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.152 Medical Device CROs Market for Biocompatibility Testing Services in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.153 Medical Device CROs Market for Sterility and Microbiology Testing Services in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.154 Medical Device CROs Market for Other Preclinical Services in Asia-Pacific, 2022-2035 (USD Billion)
Table 18.155 Medical Device CROs Market in Rest of the World, 2022-2035 (USD Billion)
Table 18.156 Medical Device CRO Market for CNS Disorders in Rest of the World, 2022-2035 (USD Billion)
Table 18.157 Medical Device CROs Market for Cardiovascular Disorders in Rest of the World, 2022-2035 (USD Billion)
Table 18.158 Medical Device CROs Market for Oncological Disorders in Rest of the World, 2022-2035 (USD Billion)
Table 18.159 Medical Device CROs Market for Bone Disorders in Rest of the World, 2022-2035 (USD Billion)
Table 18.160 Medical Device CROs Market for Respiratory Disorders in Rest of the World, 2022-2035 (USD Billion)
Table 18.161 Medical Device CROs Market for Pain Disorders in Rest of the World, 2022-2035 (USD Billion)
Table 18.162 Medical Device CROs Market for Ophthalmic Disorders in Rest of the World, 2022-2035 (USD Billion)
Table 18.163 Medical Device CROs Market for Psychological Disorders in Rest of the World, 2022-2035 (USD Billion)
Table 18.164 Medical Device CROs Market for Metabolic Disorders in Rest of the World, 2022-2035 (USD Billion)
Table 18.165 Medical Device CROs Market for Other Therapeutic Areas in Rest of the World, 2022-2035 (USD Billion)
Table 18.166 Medical Device CROs Market for Class I Devices in Rest of the World, 2022-2035 (USD Billion)
Table 18.167 Medical Device CROs Market for Class II Devices in Rest of the World, 2022-2035 (USD Billion)
Table 18.168 Medical Device CROs Market for Class III Devices in Rest of the World, 2022-2035 (USD Billion)
Table 18.169 Medical Device CROs Market for Clinical Trial Management Services in Rest of the World, 2022-2035 (USD Billion)
Table 18.170 Medical Device CROs Market for Consulting Services in Rest of the World, 2022-2035 (USD Billion)
Table 18.171 Medical Device CROs Market for Data Management Services in Rest of the World, 2022-2035 (USD Billion)
Table 18.172 Medical Device CROs Market for Regulatory Affairs Management Services in Rest of the World, 2022-2035 (USD Billion)
Table 18.173 Medical Device CROs Market for Other Clinical Services in Rest of the World, 2022-2035 (USD Billion)
Table 18.174 Medical Device CROs Market for Material Characterization and Analytical Services in Rest of the World, 2022-2035 (USD Billion)
Table 18.175 Medical Device CROs Market for Biocompatibility Testing Services in Rest of the World, 2022-2035 (USD Billion)
Table 18.176 Medical Device CROs Market for Sterility and Microbiology Testing Services in Rest of the World, 2022-2035 (USD Billion)
Table 18.177 Medical Device CROs Market for Other Preclinical Services in Rest of the World, 2022-2035 (USD Billion)

List Of Companies

The following companies and organizations have been mentioned in the report:

1. 1MED
2. 4Clinics
3. 4Pharma
4. A+ Science
5. Abiogenesis Clinpharm
6. Abond CRO 
7. Absorption Systems
8. Absorption Systems 
9. ABX-CRO
10. Acceliant 
11. Accell Clinical Research
12. AccelLAB
13. Accelovance
14. Accredited Consultants 
15. AccuLab Life Sciences
16. Accuprec Research Labs
17. Accutest Research Laboratories
18. Acorn Regulatory
19. Acrapack
20. acromion
21. aCROss Medical
22. ACT FARMA CRO
23. Activa Cro
24. ADAX International
25. Advanced Drug Development Services
26. Advanced Medical Research
27. Advena
28. Affinity Bio Partners
29. Afortiori Development
30. Afra Pharma Consultant
31. Aginko Research 
32. AICROS
33. CETERA
34. AIX Scientifics
35. AJW Technology Consultants
36. ÅKRN
37. Al Tamimi & Company
38. Alera Labs
39. Alira Health
40. Allied Clinical Management
41. Altair Clinical
42. Altasciences
43. Altiora 
44. AlvaMed
45. Amarex
46. American Preclinical Services (Acquired by NAMSA)
47. AmeRuss Clinical Trials
48. Amritt 
49. AMS
50. Amulet Capital Partners
51. Anagram
52. analyze & realize
53. Andaman Medical
54. Anteris Medical
55. Antrix
56. Aperio
57. A-Pharma
58. A-pharmaconsult
59. apices
60. Appletree CI Group
61. Applied Clinical Services
62. Applied Healthcare Research Management
63. Aragen Life Sciences
64. Arazy Group Consultants
65. Archemin
66. Archer Research
67. ArchiMed
68. ARIRDMSCRO
69. ARQon
70. Asia Actual
71. Asiatic Clinical Research
72. ATLANSTAT
73. AtoZ-CRO
74. Auriga Research
75. Australian Healthcare Solutions
76. Auxilife Scientific Services
77. Avania
78. AVANTI
79. AVIAD Life Sciences
80. AXIS Clinicals
81. Axonal-Biostatem
82. Azelix
83. Baláti
84. Barons Medical Consulting
85. Beaufort
86. BECRO
87. Beijing JRJ Science and Technology
88. BIC Group
89. BioAgile Therapeutics
90. BioClever
91. Biocodex 
92. Biomapas
93. Biomedical Regulatory Consulting
94. BioMedical Strategy 
95. Bioneeds
96. BioPharma
97. BioPlan Associates
98. Biorasi
99. BIOREG Services
100. Biostat International
101. Biotech Regulatory Solutions
102. BioTecNiKa 
103. BiTrial Clinical Research
104. BLAU Pharmaceutical Service
105. BLS laboratories
106. Boston Biomedical Associates
107. Boston MedTech Advisors 
108. Brandwood CKC
109. Bridge Pharm
110. BRIDGE PTS
111. Bright Pharmaceutical Services
112. BRIGHT Research Partners
113. BSI Life Sciences
114. C&R Research
115. Cactus Global
116. Cairo University
117. Cara Therapeutics 
118. Cardialysis
119. Cardinal Health
120. CardioMed Device Consultants 
121. Cardiovascular European Research Center (CERC)
122. CARE Research
123. Caritas Clinical 
124. Carpathian Research Group
125. CARSL Consulting 
126. Catalyst Regulatory Services
127. Catawba Research
128. Cato Research
129. CBSET
130. CC Clinical research Consultants
131. CCS Associates (CCSA)
132. CERES
133. Charles River Laboratories
134. Chemical Inspection and Regulation Service
135. Chiasma
136. Chiltern
137. China Med Device
138. Citoxlab
139. Clarivate Analytics 
140. CLINACT
141. ClinActis
142. ClinAudits
143. ClinChoice
144. ClinDatrix
145. Clinical Consulting
146. Clinical Device Group
147. Clinical Research & Compliance Consulting
148. Clinical Service Center
149. Clinical Trial Data Services
150. CliniExperts
151. Clinilabs Drug Development
152. Clinipace
153. CliniQAl™ International
154. CliniRx
155. Clinitude
156. Clinius
157. Clinlogix
158. Clinmark
159. Clinnex
160. ClinPro Research
161. Clinscience
162. ClinSearch
163. ClinSync
164. Clintec, an IQVIA Company
165. ClinVigilant
166. Cmed
167. CMIC Group
168. CMX Research
169. Cobridge
170. Cohortias
171. Commercial Eyes
172. Compliance Acuity
173. Concentrics Research
174. CONET
175. Consultys
176. Convex
177. Coronis Health
178. Costello Medical 
179. Courante Oncology
180. Covance
181. CPS Cortex
182. CR Medicon
183. Criterium
184. CRO Pharmatrendz
185. Contract Research Organization for Medical Devices & Services (CROMDS)
186. Cromos Pharma
187. CROMSOURCE
188. CROS
189. CROs NT
190. Crown CRO
191. CRS Clinical Research Services
192. CSSi LifeSciences
193. CTC North
194. CTI
195. CTNT
196. CurAccel
197. Cvigilance
198. CW Research & Management
199. CYA Medical Device Consulting
200. Dalia Givony, Regulatory & Clinical Consulting
201. Databean
202. Datapharm Australia
203. De Groot Technical Services
204. DEKRA
205. Denothex
206. Devicia
207. Dexcom
208. DH RegSys
209. dicentra
210. DKSH Marketing Services Spain
211. dMed
212. Donawa Lifescience Consulting
213. Dor Pharmaceutical Services
214. Dove Quality Solutions
215. DP Clinical
216. Dr. Notghi Contract Research
217. DreamCIS
218. Drug Development and Regulation
219. DSA Consultants
220. DZS Clinical Services
221. EAS Consulting Group
222. East BS Clinical Research
223. ECLEVAR MEDTECH
224. ECSOR
225. Edwards Lifesciences
226. Egmont Group
227. Element
228. Emergent Clinical Consulting
229. Emergo
230. Emmes
231. En Pointe Clinical Research
232. Engel, Hellyer & Partners 
233. e-novex
234. Envigo
235. EPIC Research
236. EPS International
237. EskeGen
238. ESTERN Medical
239. ETAP-Lab
240. ethica CRO
241. Ethicare Remedies
242. EuDRAcon 
243. Eupraxia
244. Euraxi 
245. Eurofins Medical Device Testing 
246. The European Bioinformatics Institute (EMBL-EBI)
247. Europital
248. Everest Clinical Research
249. Evidilya
250. Exalon 
251. Excelya
252. eXcorLab
253. Exom
254. Experior
255. ExperTrials
256. Farzan Clinical Research
257. FDAInsight
258. FGK Clinical Research
259. Firma Clinical Research
260. Five Corners
261. Focal Point Research
262. Formac Pharmaceuticals
263. Frestedt
264. Freyr
265. Gateway
266. GCP-Service International
267. genae
268. Genco Medical
269. Genelife Clinical Research
270. GenesisCare Clinical
271. GENOTRIX
272. Genpact
273. George Clinical
274. Getz Healthcare
275. GKM Medical Device Group
276. Global Center for Medical Innovation 
277. Global Pharma Tek
278. Global Regulatory Affairs
279. Global Regulatory Partners
280. Global Regulatory Services 
281. GLyPharma
282. GlyTech
283. GMED
284. Greenlight Clinical
285. Grove Group
286. Gsap
287. Hangzhou Tigermed Consulting
288. Harmony Clinical Research
289. Hart Clinical Consultants
290. Health Decisions
291. Healthcare International Partners
292. HealthCore
293. HealthLink
294. Highthink
295. Hilbert Paradox
296. HingeClinica
297. Honeywell
298. HungaroTrial
299. i3 Consulting 
300. IBEX Preclinical Research
301. ICBio 
302. ICCR-Roßdorf 
303. ICON
304. ICRC-Weyer
305. ICTA
306. IDConic
307. Illingworth Research Group
308. ILS 
309. IMARC
310. Inamed
311. Innomar Strategies
312. Innovo Medical
313. Inotiv
314. Inrextest
315. InSightec
316. Integrated Resources
317. Integrium
318. Intellim
319. International Drug Development Institute 
320. International HealthCare
321. Intertek
322. INTOX
323. Ipsum
324. IQVIA
325. Iris Pharma
326. Ironstone Product Development 
327. IRW
328. ISA HEALTH
329. Iuvo
330. IVD Consultants
331. IVDeology
332. IZiel Healthcare
333. Knipper Health
334. Japan MDC (JMDC)
335. JERELO
336. Johns Hopkins University
337. JSS Medical Research
338. Jyton
339. Kangan Pharmaceutical Consulting
340. KCR
341. KCRI
342. KD&A
343. Ken Block Consulting
344. Dentons Kensington Swan 
345. Keystone Regulatory Services
346. KLIFO
347. Knoell
348. Kobridge Consulting
349. KPS Clinical Services
350. Krescent Medical Research
351. L.S. Marketing & Registration
352. L3 Healthcare
353. LabCorp
354. Lahav
355. Lambda Therapeutic Research 
356. Larix
357. Lean RAQA
358. Leon Research
359. Likak Research
360. Li-Med
361. Linical Americas
362. LINK Medical
363. LIONBRIDGE
364. Liveon Biolabs
365. LNAge
366. Macnair Consultants
367. Made Consulting
368. MakroCare
369. Malca Chen-Zion Group
370. MANDALA International
371. Marti Farm
372. Massachusetts General Hospital
373. MasterControl
374. MAXIS
375. Mayo Clinic
376. McCarthy Consultant Services
377. MD Pharma Consulting 
378. MD101Consulting 
379. MD-Clinicals
380. mdi Europa
381. MDP-Solutions
382. MED Institute
383. Medanex Clinic
384. Medelis
385. Medfiles
386. Medical Equipment Compliance Associates
387. Medical Trials Analysis
388. Mediclin Clinical Research
389. Medicomp
390. Mediconomics
391. MEDICRO
392. MedicSense
393. Medidee
394. MEDIKAPOLI
395. MediqTrans
396. MEDITRIAL
397. MedNet
398. Medpace
399. MedPass International
400. MedQ Consultants
401. MedTech Impact Partners 
402. MedTrials
403. Medtronic
404. MedVigil
405. Medvinbio Labs
406. Mene Research
407. Mericon
408. Meshayu Consultants
409. MethodSense
410. Metrics Research
411. Metronomia
412. MIC Medical
413. Micren Healthcare
414. Mid-Link Consulting
415. MileStone Research
416. MMS
417. Mn Solutions
418. Mobius Medical 
419. MonitorCRO
420. Morley Research Consortium
421. Morula HealthTech
422. MPI Research
423. Mprex Healthcare
424. Musculoskeletal Clinical Regulatory Advisers
425. NAMSA
426. National Cancer Institute
427. National Institute of Mental Health
428. Navitas Life Sciences
429. NCGS
430. Nelson Labs
431. Neomed
432. Neometrix Consulting
433. Neopharm
434. Neox
435. Neozene
436. Nerac
437. Noble Life Sciences
438. Northlane Capital Partners
439. Norwich Clinical Research Associates
440. NovaTrials
441. Novem Healthcare
442. Novocure
443. Novum
444. NoyMed
445. NSF International
446. Nuvisan Pharma Services
447. Nyprax Pharma
448. O4 Research
449. Obelis Group
450. Odelle Technology
451. Onorach
452. Opera
453. Operon Strategist
454. OPIS
455. Optimal Pharm/Tox Consulting
456. Optimal Research
457. Optimapharm
458. Ora
459. Osmunda
460. OThree Consulting
461. Pace
462. Pacific BioLabs
463. Pacific Bridge Medical
464. Pacific Clinical Research Group
465. Pamplona Capital Management
466. Paradigm Research
467. PAREXEL
468. PaxMed
469. PCT Lab Research
470. PDC Healthcare
471. Peachtree BioResearch
472. Pearl Pathways
473. Pepgra
474. Perfect Pharmaceuticals Consultants 
475. Perfection-CRO
476. Pfarrell Medical
477. Pharma To Market
478. Pharmaco-Kinesis
479. Pharmahungary Group
480. PharmaLex
481. Pharmalog
482. PharmaMed Research
483. Pharmaron
484. Pharmaseed
485. PharmaSols
486. Pharmaspecific
487. PharmDedict 
488. PharmEng Technology
489. Pharm-Olam
490. PharmOut
491. Phidea Group
492. Pilgrim Quality Solutions
493. Pine Lake Laboratories
494. Pivotal
495. PMI Preclinical
496. PPD
497. PQE Group
498. PRA Health Sciences
499. PRADO
500. PRC Clinical
501. Preclinical Medevice Innovations
502. PreClinical Pathfinder
503. Pre-Clinical Research Services
504. Premier Research
505. Primacyt
506. proDERM
507. Regulatory Affairs Professionals Society
508. Profil 
509. ProMedica
510. ProMedoss
511. PROMETRIKA
512. ProPharma Group
513. ProRelix Research
514. ProSciento
515. Prosoft Clinical
516. ProtoMed
517. ProTrials
518. Proxima Clinical Research
519. Pharmaceutical and Regulatory Services
520. Q&R Canada
521. QA Consulting
522. QAdvis
523. Qmed Consulting
524. QPS
525. Qserve Group
526. Q-Trials
527. QUADRO CRO
528. Qualitiso
529. Quality and Compliance Consulting
530. Qualtech
531. Quanticate
532. QUNIQUE 
533. QVigilance
534. R & C Consulting 
535. R&G PharmaStudies
536. RAHE Life Science
537. RAMED
538. Ratos
539. RAY
540. RCQ Solutions
541. RCRI
542. RCTs
543. Reg-Affairs & QualiPractixis
544. RegDesk
545. Registrar Corp
546. Regulatory Compliance Associates
547. Regulatory Insight
548. Reimbursement Strategies
549. Reliance Life Sciences
550. Research Professionals
551. Rho
552. RJR Consulting
553. Rocketpharm
554. Rook Quality Systems
555. Rotrial Contract Research
556. RQM+
557. RQMIS
558. RQSolutions
559. RTI Health Solutions 
560. Scandinavian CRO
561. Scandinavian Regulatory Services
562. SCiAN Services
563. SCIderm
564. SCIRENT
565. Scope International
566. SDC
567. SeerPharma
568. Sentez CRO
569. Seoul CRO
570. SEQ 
571. SGS
572. Shanghai QiSheng Business Consulting
573. Shenzhen Advanced Medical Services
574. Sidley Austin
575. Simmons & Simmons
576. SIPRA LABS
577. SIRO Clinpharm
578. Siron Clinical
579. Sixmurs Group
580. SLF
581. Smerud Medical Research
582. Smith+Nephew
583. SMS-Oncology
584. Sourcia
585. Southern Star Research
586. SPARTA
587. Specipig
588. Spectrum Clinical Research
589. SPharm
590. SPRIM Advanced Life Sciences
591. SRD
592. SRG Healthcare
593. Stanford University
594. StarFish Medical
595. Stat One
596. STATKING Clinical Services 
597. Steinberg Research Solutions
598. SteriPack Group
599. SterlingBio
600. Strategic Compliance International
601. StrugoPharm
602. Sumika Chemical Analysis Service
603. SunFlare
604. Surpass
605. Surpass-Silicon Valley
606. Symbio
607. Symbion Research
608. Syncorp Health
609. Syneos Health
610. Syntactx
611. Syntax
612. Synteract
613. Syreon
614. Szasz&Co.
615. TAB Clinical
616. Target Health
617. TCA Clinical Research
618. Technical Resources International
619. TechnoSTAT
620. TentaMedix
621. TFS HealthScience
622. The Clinical Trial Company 
623. The CRO Group
624. The Medical Affairs Company
625. Thema Med
626. Theo Manufacturing 
627. Theorem Clinical Research
628. TheraGenesis
629. Therapeutics
630. Think Research
631. Tigermed
632. Toolbox
633. Toxikon
634. TransPerfect Life Sciences
635. Trial Form Support International
636. Trial Runners
637. Triangle Research Solutions
638. TriMetis
639. Turacoz Healthcare Solutions
640. TÜV SÜD-Healthcare & Medical Devices
641. Underwriters Laboratory
642. Unikal Consultants
643. University of California
644. VA Office of Research and Development
645. Valliscor
646. Vantage BioTrials
647. Vastrax
648. Veeda Clinical Research
649. Venn Life Sciences
650. Veristat
651. VIMTA 
652. Visioncare Research
653. vivo Science (a Texcell acquired company)
654. Vivotecnia
655. VOLER Biotech Consulting
656. Vyomus Consulting
657. WCCT Global
658. WCG ThreeWire
659. WDB Holdings
660. Winicker Norimed
661. Wipro
662. Wonderville
663. Woodley BioReg
664. Worldwide Clinical Trials
665. WuXi AppTec
666. Zi-Medical
667. Zimmer Biomet
668. Zwiers Regulatory Consultancy